Equity Purchase. Executive shall be eligible to purchase an initial amount of Equity in Niles LLC for payment as agreed upon between Niles LLC and the Executive.
Equity Purchase. (1) Party B hereby irrevocably grants to Party A the right to purchase at any time, or designate any third party to purchase, all or part of Party B’s equity interest in Party C, provided permitted under Chinese laws and regulations. Apart from Party A or any third party designated by Party A, no other person shall have the right to purchase such equity interest. Party C agrees to such grant by Party B to Party A. For the purpose of this Agreement, a “third party” or a “person” may be a natural person, company, partnership, enterprise, trust agency or other non-corporate entity.
Equity Purchase. Concurrent with the execution of this Agreement, Biogen Idec shall purchase thirty million U.S. dollars ($30,000,000) of AVEO’s Series E Convertible Preferred Stock, $.001 par value per share, at a purchase price of $4.00 per share, pursuant to, and in accordance with the terms of, the form of Stock Purchase Agreement attached to this Agreement as Exhibit C.
Equity Purchase. 19 12. CONFIDENTIALITY.........................................................................................19
Equity Purchase. Pursuant to the Stock Purchase Agreement, PathoGenesis shall purchase Two Million Five Hundred Thousand Dollars ($2,500,000) of Series E Preferred Stock of AeroGen, at a purchase price of $2.60 per share.
Equity Purchase. ICN and Schering-Plough Corporation are contemporaneously with this Agreement entering into the Stock Purchase Agreement.
Equity Purchase. On the Execution Date, Licensee and Company shall execute (a) a Stock Purchase Agreement, pursuant to which (i) Licensee will purchase 3,000,000 shares (the “Purchased Shares”) of common stock, par value $0.01 per share, of Company (“Common Stock”) for an aggregate purchase price of $14,691,930 and (ii) Company will execute and deliver to, and in favor of, Licensee, a warrant on customary terms reasonably acceptable to Licensee (the “Warrant”), pursuant to which Licensee will have the right, until February 10, 2020, to purchase up to 8,655,804 shares (the “Warrant Shares”) of Common Stock at an exercise price of $4.90 per share (in each case, subject to adjustment in accordance with the terms of the Warrant), and (b) a Registration Rights Agreement, pursuant to which Company will agree to register the Purchased Shares and the Warrant Shares.
Equity Purchase. Simultaneous with the execution of this Agreement Cephalon and Angioblast have entered into that certain Stock Purchase Agreement dated as of even date herewith by and among Angioblast, Cephalon and the individuals and entities listed on the exhibits thereto pursuant to which Cephalon shall purchase certain currently outstanding equity securities of Angioblast in accordance with the terms of such agreement.
Equity Purchase. Upon execution of this Agreement, ImClone shall purchase 1,000,000 shares (on a pre-split basis and subject to adjustment) of Common Stock of CombiChem at a per share purchase price equal to $2.00 per share for an aggregate purchase price of U.S. $2 million, pursuant to the terms of that certain Common Stock Purchase Agreement, dated as of the Effective Date, by and between CombiChem and ImClone (together with all ancillary agreements thereto, the "Stock Purchase Agreement"). In the event that CombiChem closes an initial public offering of its common stock at a sales price per share to the public (the "IPO Price") which is less than $2.50 per share (on a pre-split basis), then, upon the closing of such initial public offering, CombiChem shall issue to ImClone, without further consideration other than the purchase price paid by ImClone pursuant to the Stock Purchase Agreement, such additional number of shares of CombiChem common stock equal to: 2,000,000 -------------- = 1,000,000 Adjusted Price wherein the "Adjusted Price" = the IPO Price X .80 if the IPO Price is less than $2.50 per share. All shares of CombiChem common stock issued pursuant to this Section 8.1 shall be deemed to be "Shares" within the meaning of the Stock Purchase Agreement.
Equity Purchase. During the period from July 10, 2000 through and including June 30, 2001, (i) Executive may from time to time purchase, and upon Executive's election to purchase the Company will cause there to be sold to Executive, an aggregate of up to $250,000 of Investment Units in LLC consisting of equal numbers of Preferred Interests at a purchase price of $0.6265 per unit and Class A Equity at a purchase price of $0.3735 per unit, and (ii) in the event that Executive exercises his election to purchase any or all of the Investment Units he is entitled to purchase pursuant to Section 1.5(b), Executive may from time to time purchase, and upon Executive's election to purchase the Company will cause there to be sold to Executive, additional Investment Units in LLC up to the same aggregate amount as such Investment Units purchased pursuant to Section 1.5(b), payable by a demand note (the "Demand Note") made by Executive to LLC or its designee on the following terms and conditions: (A) interest will accrue on the unpaid amount of the Demand Note at the per annum rate equal to the per annum rate of interest as reported by the Wall Street Journal from time to time as the "prime rate" (the "Prime Rate"); (B) interest will accrue at the per annum rate equal to the Prime Rate plus 2% upon the failure of Executive to pay on demand any unpaid principal amount or unpaid interest on the Demand Note; and (C) the Demand Note will be full recourse to the assets of Executive. The consummation of such purchases will be subject to Executive then being Executive Vice President of Corporate Development and Operations of Precision as of the date of each such purchase. In addition, the Company will cause there to be granted to Executive the opportunity to purchase additional Investment Units in LLC consisting of Preferred Interests and Class A Equity in connection with future additional equity investments in LLC in an amount to be determined by the Company Board in its discretion. The Company will grant or cause there to be granted to Executive, as the case may be, customary "piggyback" registration rights (subject to customary underwriter cutback provisions) with respect to his equity interest in LLC in connection with Public Offerings of Voting Securities of LLC or a Precision Company in which Precision Partners Investment Fund, L.L.C. ("Precision Investors") participates. The parties understand that Executive will be entitled to participate (up to 25% of the Voting Securities then owned b...
